Arizona’s HonorHealth Research Institute First to Investigate Combination of Atovaquone & Azithromycin in COVID-19 Patients

Arizona’s HonorHealth Research Institute First to Investigate Combination of Atovaquone & Azithromycin in COVID-19 Patients

HonorHealth Research Institute commenced a clinical trial at three of its Arizona hospitals in Scottsdale and Phoenix to test a novel combination of atovaquone, a drug used to treat malaria and azithromycin, an antibiotic in a clinical trial to treat moderate to severe cases of SARS-COV-2, the virus behind the COVID-19 pandemic. This is the first such clinical trial in the United States involving this drug combination in connection to COVID-19 and Arizona leads the research charge.

The Problem: SARS-CoV-2

Michael Gordon, MD, a Co-principal investigator of the trial and Medical Director with HonorHealth Research Institute reports that doctors, scientists and researchers don’t yet understand this pathogen and cannot elucidate much of this disease. He noted, “A big challenge is about 80% of individuals develop flu-like symptoms for up to two weeks. Most of those go on to do well. But a subset, those at high risk who are over the age of 60, have diabetes, untreated hypertension and underlying illnesses that could suppress the immune system, about 15% of patients have a much more malignant progress.” For those that fall into the severe to critical category the virus can quickly g...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee